Skip to main content

28-08-2018 | Rheumatoid arthritis | Article

Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care: 2-year outcomes and predictors

Brahe CH et al. Rheumatology (Oxford) 2018: key244. doi: 10.1093/rheumatology/key244

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

Related topics